These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 1638587

  • 1. Cefprozil versus cefaclor in the treatment of mild to moderate skin and skin-structure infections. The Cefprozil Multicenter Study Group.
    Parish LC, Doyle CA, Durham SJ, Wilber RB.
    Clin Ther; 1992; 14(3):458-69. PubMed ID: 1638587
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential.
    Wiseman LR, Benfield P.
    Drugs; 1993 Feb; 45(2):295-317. PubMed ID: 7681376
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population.
    McCarty J, Ruoff GE, Jacobson KD.
    Am J Med; 1992 Jun 22; 92(6A):80S-85S. PubMed ID: 1621751
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A comparative study of the efficacy, safety and tolerability of azithromycin and cefaclor in the treatment of children with acute skin and/or soft tissue infections.
    Montero L.
    J Antimicrob Chemother; 1996 Jun 22; 37 Suppl C():125-31. PubMed ID: 8818853
    [Abstract] [Full Text] [Related]

  • 10. Treatment of pharyngitis and tonsillitis with cefprozil: review of three multicenter trials.
    McCarty JM, Renteria A.
    Clin Infect Dis; 1992 Jun 22; 14 Suppl 2():S224-30; discussion S231-2. PubMed ID: 1617042
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections.
    Ball P.
    Eur J Clin Microbiol Infect Dis; 1994 Oct 22; 13(10):851-6. PubMed ID: 7889959
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of cefprozil and cefaclor for treatment of acute urinary tract infections in women.
    Iravani A.
    Antimicrob Agents Chemother; 1991 Sep 22; 35(9):1940-2. PubMed ID: 1952874
    [Abstract] [Full Text] [Related]

  • 14. Treatment of skin and skin structure infections: a comparative study of Augmentin and cefaclor.
    Parish LC, Aten EM.
    Cutis; 1984 Dec 22; 34(6):567-70. PubMed ID: 6394217
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical and laboratory studies with cefaclor: efficacy in skin and soft tissue infections.
    Dillon HC, Gray BM, Ware JC.
    Postgrad Med J; 1979 Dec 22; 55 Suppl 4():77-81. PubMed ID: 548944
    [Abstract] [Full Text] [Related]

  • 18. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis.
    Dere WH, Farlow D, Therasse DG, Ruoff GE.
    Clin Ther; 1992 Dec 22; 14(1):41-53. PubMed ID: 1576625
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.